Comparison of the therapeutic efficacy of pregabalin and duloxetine in peripheral neuropathy induced by taxanes containing chemotherapy regimens in women with breast cancer, a randomized clinical trial.
Phase of Trial: Phase II
Latest Information Update: 01 Mar 2018
At a glance
- Drugs Duloxetine (Primary) ; Pregabalin (Primary)
- Indications Peripheral neuropathies
- Focus Therapeutic Use
- 22 Feb 2018 Planned number of patients changed from 70 to 82.
- 22 Feb 2018 Status changed from recruiting to completed.
- 21 Sep 2016 New trial record